KRW 408.0
(-0.24%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 339.3 Billion | 324.26 Billion | 296.85 Billion | 279.98 Billion | 269.64 Billion | 211.22 Billion |
Cost of Revenue | 174.46 Billion | 166.65 Billion | 143.35 Billion | 120.4 Billion | 123.16 Billion | 137.61 Billion |
Gross Profit | 164.83 Billion | 157.61 Billion | 153.5 Billion | 159.57 Billion | 146.47 Billion | 73.6 Billion |
Operating Expenses | 167.76 Billion | 163.2 Billion | 163.9 Billion | 157.55 Billion | 156.31 Billion | 73.7 Billion |
Selling, General and Administrative Expenses | 167.76 Billion | 163.2 Billion | 163.9 Billion | 157.55 Billion | 156.31 Billion | 73.7 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | -226.58 Million | -898.59 Million | 979.68 Million | - | - |
Cost and Expenses | 325.23 Billion | 329.86 Billion | 307.26 Billion | 277.95 Billion | 279.48 Billion | 211.31 Billion |
Operating Income | 14.06 Billion | -5.59 Billion | -10.4 Billion | 2.02 Billion | -9.84 Billion | -98.36 Million |
Interest Expense | 4.73 Billion | 1.84 Billion | 1.31 Billion | 1.54 Billion | 1.55 Billion | 7.36 Million |
Income Tax Expense | -304.88 Million | 1.4 Billion | 6.41 Billion | 1.75 Billion | 905.19 Million | 467.19 Million |
Earnings before Tax | 43.98 Billion | -36.62 Billion | 42.64 Billion | 20.04 Billion | 3.56 Billion | -200.91 Million |
Net Income | 43.42 Billion | -38.89 Billion | 30.18 Billion | 15.99 Billion | 2.62 Billion | -668.11 Million |
Earnings Per Share Basic | 192.50 | -136.87 | 156.98 | 86.17 | 12.67 | -3.22 |
Earnings Per Share Diluted | 192.50 | -136.87 | 156.98 | 86.17 | 12.67 | -3.22 |
Weighted Average Shares Outstanding | 225.58 Million | 284.18 Million | 206.61 Million | 207.29 Million | 207.29 Million | 207.29 Million |
Weighted Average Shares Outstanding (Diluted) | 225.58 Million | 284.18 Million | 206.61 Million | 207.29 Million | 207.29 Million | 207.29 Million |
Gross Margin | 0.49 | 0.49 | 0.52 | 0.57 | 0.54 | 0.35 |
EBIT Margin | 0.04 | 0.03 | 0.03 | 0.08 | 0.04 | 0.06 |
Profit Margin | 0.13 | -0.12 | 0.10 | 0.06 | 0.01 | -0.00 |
EBITDA | 13.75 Billion | -18.4 Billion | 63.83 Billion | 23.99 Billion | 24.58 Billion | 13.11 Billion |
Earnings Before Tax Margin | 0.04 | -0.02 | -0.04 | 0.01 | -0.04 | -0.00 |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 95.67 Billion | 91.15 Billion | 97.85 Billion | 339.3 Billion | 87.68 Billion | 79.59 Billion |
Cost of Revenue | 55.09 Billion | 50.44 Billion | 57.84 Billion | 174.46 Billion | 44.41 Billion | 39.17 Billion |
Gross Profit | 40.58 Billion | 40.7 Billion | 40 Billion | 164.83 Billion | 43.26 Billion | 40.41 Billion |
Operating Expenses | 46.32 Billion | 46.29 Billion | 44.06 Billion | 168.5 Billion | 42.43 Billion | 40.69 Billion |
Selling, General and Administrative Expenses | 46.32 Billion | 46.29 Billion | 44.06 Billion | - | 42.43 Billion | 40.69 Billion |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | -50.99 Billion | -55.2 Million | 1.58 Billion | -1.41 Billion | -1.86 Billion | -699.33 Million |
Cost and Expenses | 101.41 Billion | 96.73 Billion | 101.9 Billion | 342.96 Billion | 86.84 Billion | 79.87 Billion |
Operating Income | -5.73 Billion | -5.58 Billion | -4.05 Billion | -3.66 Billion | 833.24 Million | -281.43 Million |
Interest Expense | 1.54 Billion | 2.24 Billion | 2.17 Billion | 4.73 Billion | 1.56 Billion | 694.05 Million |
Income Tax Expense | -1.78 Billion | 1.28 Billion | -478.65 Million | -304.88 Million | -375.63 Million | 460.46 Million |
Earnings before Tax | -9.44 Billion | 10.36 Billion | 6.14 Billion | 43.07 Billion | -2.72 Billion | 21.68 Billion |
Net Income | -9.91 Billion | 15.72 Billion | 4.96 Billion | 43.42 Billion | -1.35 Billion | 22.38 Billion |
Earnings Per Share Basic | -48.52 | 78.99 | 26.13 | - | -5.90 | 113.23 |
Earnings Per Share Diluted | -48.52 | 78.99 | 26.13 | - | -5.90 | 113.23 |
Weighted Average Shares Outstanding | 204.27 Million | 199.07 Million | 190.02 Million | 226.05 Million | 229.5 Million | 197.69 Million |
Weighted Average Shares Outstanding (Diluted) | 204.27 Million | 199.07 Million | 190.02 Million | 226.05 Million | 229.5 Million | 197.69 Million |
Gross Margin | 0.42 | 0.45 | 0.41 | 0.49 | 0.49 | 0.51 |
EBIT Margin | -0.01 | -0.01 | 0.00 | - | 0.06 | 0.05 |
Profit Margin | -0.10 | 0.17 | 0.05 | 0.13 | -0.02 | 0.28 |
EBITDA | -707.83 Million | -841.06 Million | 362.75 Million | - | 5.18 Billion | 4.05 Billion |
Earnings Before Tax Margin | -0.06 | -0.06 | -0.04 | -0.01 | 0.01 | -0.00 |
BIOIF
ANRG
ZIMLAB
ALTRI
ECOM
REMEDY